🇺🇸 FDA
Patent

US 8992886

Cyclic peptide analogues for non-invasive imaging of pancreatic beta-cells

granted A61KA61K51/088A61P

Quick answer

US patent 8992886 (Cyclic peptide analogues for non-invasive imaging of pancreatic beta-cells) held by The Board of Regents of the University of Texas System expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K51/088, A61P, A61P3/10